Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

AIFMD Seen as Most Unclear Regulatory Development in the Alternatives Industry

Thursday, January 26, 2012

Lord Paul Myners
Opalesque Industry Update - Over a third of delegates at a recent IMS Group (IMS) regulatory forum expressed the view that the Alternative Investment Fund Managers Directive, remains the most uncertain aspect of financial regulation in terms of its final substance and resultant effect on the industry.

The conference which was held at Bloomberg in London yesterday, played host to over two hundred delegates from the UK asset management and securities industry, including hedge fund managers, private equity firms, fund of funds, prime brokers and lawyers.

According to a survey conducted by IMS, the leading regulation and compliance consultancy, 31% of delegates found that AIFMD raises the most questions when considering the direct impact it will have on fund managers.

Additionally, nearly a quarter of delegates (23%) said that AIFMD will have the most impact in terms of direct cost and necessary change to operating and compliance procedures.

Delegates were also concerned about the impact of UK regulatory change (33%), FATCA (8%), SEC Registration (8%) and MiFID II (7%) on costs to businesses and on implementation of necessary changes to compliance and operating procedures.

Key note speaker Lord Paul Myners said: “The tide of regulation is only going to get stronger and the regulatory landscape will become even more difficult to negotiate. The process of AIFMD is a moveable feast with the ability to throw up constant surprises. The uncertainty surrounding financial regulation is enormous and it is impossible to fully comprehend the impact it will have on businesses. The buyside needs to get better at lobbying on regulation from the outset and actively engage with the regulators.”

Peter Moore, head of regulation at the IMS Group, said: “The results of the survey highlight the need for greater understanding of AIFMD and other regulatory regimes affecting the market. The cost/benefit reports of EU regulation are conspicuous by their absence.”

Press Release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner